MedTech Spectrum

Article Name Medtech Thought Leader's

Real-world strategies for addressing disparities in healthcare access

Healthcare is a human right, yet it remains out of reach for many. Over half of the world’s population lacks safe, affordable, and timely healthcare, making it imperative to address this challenge.

03rd October, 2024

Unlocking Healthcare's Digital Frontier with Hospital Information Management Systems

Innovative Hospital Information Management Systems are emerging as game-changers, digitising the healthcare sector

27th June, 2024

"We are expanding our presence in the US, Africa and the Middle East"

Pune-based startup DeepTek is a leading company developing artificial intelligence (AI) solutions that empower healthcare professionals to improve early detection, diagnosis, and treatment of various medical conditions. Their flagship platform, Augmento, seamlessly integrates AI tools into existing radiology workflows, while Genki, another AI solution, focuses on lung health screening in resource-limited settings, particularly tuberculosis (TB). Ritika Taki, Director, Strategic Projects, DeepTek spoke to Medtech Spectrum in detail about how the startup is tackling the growing burden of TB in India, and also shared plans about the company' current projects and future plans.

27th June, 2024

Curbing NCD epidemic: Leveraging integrated point-of-care diagnostic devices

Point-of-Care diagnostics represents a powerful tool in the fight against Non-Communicable Diseases

17th May, 2024

“Early diagnosis through advanced screening tech, coupled with heightened awareness is crucial”

The oncology market in India is steadily growing, driven by an increasing cancer incidence and a strong demand for advanced treatments. However, there remains substantial untapped potential, primarily in improving access to cutting-edge therapies and expanding reach to underserved regions. Glenmark Pharma, with its patient-centric approach and innovative solutions, has been steadily increasing its market share by introducing high-quality and affordable cancer drugs. Alok Malik, President & Business Head - India Formulations, Glenmark Pharmaceuticals Ltd, in an exclusive interview with MedTech Spectrum & BioSpectrum, spoke at length about the company’s mission to enhance access to high-quality cancer care in India and the untapped market potential, new launches and the plans ahead.

28th February, 2024

Boston Scientific appoints Madan Krishnan to lead India subcontinent

Krishnan is an international business leader with more than two decades of progressive leadership experience

19th February, 2024

“Rapid evolution of technologies, biopharmaceuticals, and genomic medicine are reshaping the healthcare sector”

Terumo India, the Indian arm of Japan-based medtech firm Terumo Corporation, has recently announced the launch of new medical tools, intended for use in the management of liver cancer. With World Cancer Day, on February 4, 2024, calling to improve prevention, detection and treatment of cancer, new products are being launched in the Indian market to shape a way forward. MedTech Spectrum & BioSpectrum India spoke to Shishir Agarwal, President and Managing Director, Terumo India about the current scenario of the oncology medical devices market in the country.

02nd February, 2024

3D Printing Our Way to the Future of MedTech

Care is becoming more personalized. Innovation cycles are growing shorter and shorter. Healthcare companies are increasingly looking for ways to eliminate waste and complexity. These are only a few of the reasons why 3D printing has become such an invaluable tool for MedTech research and design teams. 3D printing can make the impractical a reality. It can help providers customize devices to meet the unique care needs of individual patients almost immediately. It’s now even possible to 3D print medicine and simulated body parts.

30th January, 2024

8 Major Trends in Patient-Centric Care

Health policies and regulations influence the accessibility, affordability, and quality of healthcare services, striving to create a balance that meets the needs of diverse populations. However challenges persist within healthcare systems globally, including issues of healthcare disparities, rising costs, and the need for ongoing innovation. The integration of data-driven approaches, such as electronic health records and health informatics, seeks to enhance efficiency, coordination, and personalised care.

08th January, 2024

Biomedical Innovation: Answer for Climate-sensitive Diseases

The world is finally paying attention to the impact of climate change on neglected diseases. What we need now is medical innovation.

08th January, 2024

“The Open Innovation Program has become a trend in the molecular diagnostics industry”

Established in 2000, South Korea based Seegene Inc is a leader in molecular diagnostics and achieved remarkable financial success with over $1 billion in revenue and 65 per cent gross margins. With a mission for a disease-free world and proactive pandemic prevention, Seegene seamlessly integrates high multiplex diagnostic assays with automated testing systems. In an interaction with BioSpectrum & MedTech Spectrum, Dr Seong-Youl Kim, Seegene's Senior Vice President, shares insights on the company, the molecular diagnostics landscape, challenges and opportunities etc.

08th January, 2024

Targeted Battle Against HPV

Since the launch of the global strategy against cervical cancer in 2020, the World Health Organization (WHO) has accelerated the initiative by virtue of commitments and strategies offered by governments and organisations worldwide. Australia is on track to become one of the first nations to achieve this, and countries like Bangladesh and Indonesia have introduced HPV vaccines. Let's examine Asia's efforts in eliminating cervical cancer and whether the continent is on track to meet WHO’s targets by 2030.

08th January, 2024

Urology of Virginia Announces New Chief Executive Officer

Dr. Joshua Langston Assumes Role of Managing Partner and CEO at Urology of Virginia

02nd January, 2024

Focusing on Women's Cancers

Breast and cervical cancer are pressing threats to women and health systems in the Asia Pacific (APAC) region. A new multisectoral collaboration and a powerful analysis of six countries’ breast and cervical cancer prevention and care capacity are generating momentum to save lives and contribute to a global health movement.

13th December, 2023

NEOM is fundamentally reshaping health by placing a strong emphasis on personalised care

The core of a holistic health reform lies in the integration of emerging cutting-edge technologies into personalised care, emphasising interdisciplinary approaches. To fulfil the burgeoning healthcare requirement, Saudi Arabia is investing $500 billion to build an integrated megaproject region, NEOM, to create a human-centric care model through innovative systems, policies and infrastructure marvels. NEOM is forging to become a global benchmark for innovative technology, research, and education designing advanced treatments and comprehensive care. NEOM's holistic human-centred approach simplifies medical specialisations and gives individuals easy access to their medical profiles. Dr Mahmoud Alyamany, Head of NEOM Health, Wellbeing Sector elaborated on the futuristic health model during his recent visit to Singapore over ‘Discover NEOM’ global tour.

06th November, 2023

Disruptive Technologies and New Industry Initiatives for Diabetes Management

Asia will continue to be a large and rapidly growing market for diabetes care technologies. To be competitive and successful in the aggressive market with numerous large and startup companies, players will need large funds, a broad portfolio with desirable differentiators and a strong distribution network. Low-cost products, subscription-based solutions, reimbursement policies and training of patients and physicians will be required to promote the adoption among low income and middle-income regions. Large players are very intent on tapping the large market potential in Asia. Many global companies have set up local presence in Asian countries and local production through original equipment manufacturer (OEM) partners in the countries to bring down the cost of their solutions, and more companies are expected to follow

06th November, 2023

“Medtronic aims to foster collaboration with local ecosystem and stakeholders in Hyderabad”

In a significant move towards the growth of the healthcare technology sector in India, Ireland-headquartered Medtronic had announced an investment of approximately Rs 3000 crore, earlier this year, to expand the Medtronic Engineering & Innovation Center (MEIC) in Hyderabad. MEIC is Medtronic’s largest research and development (R&D) centre outside of the US. In addition, Medtronic is supporting the Government of Telangana’s efforts to position Hyderabad as a global hub for healthcare technology research and innovation. In conversation with MedTech Spectrum & BioSpectrum, Divya Prakash Joshi, Vice President & MEIC Site Leader, Medtronic talks about the new investment and the future plans of MEIC.

23rd October, 2023

Shaping the Future of Anaesthesia and Critical Care in India: An Exclusive Interview with Shalin Patel, Managing Director of Draeger India Group

On the occasion of World Anaesthesia Day, MedTech Spectrum & BioSpectrum India delve into the dynamic world of healthcare and technological innovation. We had the privilege of speaking with Mr. Shalin Patel, the Managing Director of Draeger India Group, a prominent player in the medical and safety technology sector.

16th October, 2023